In this study 34% of the participants had diabetes, Results: LCZ696 was superior to enalapril in reducing the risks of death and of hospitalization for heart failure (NEJM)
Diabetes News Service
Glycosmedia is also available as an App:
For iPhone and iPad | For Android devices
Sponsorship and Advertising
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
